Arturo Monta, MD
Internal Medicine · Toms River, NJNPI 1790732089
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 70 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 16 manufacturers, the largest accounting for just 20.7% — the pattern of someone who eats at a lot of different presentations.
Across 70 payments — averaging $20.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$295
- AstraZeneca$196
- Bayer$186
- Lilly USA, LLC$172
- Abbott$160
- Xeris Pharmaceuticals, Inc.$125
- plus $292 from 10 others
What the payments were for
- Food & beverage$1,426100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 22 | $295 |
| AstraZeneca | 6 | $196 |
| Bayer | 6 | $186 |
| Lilly USA, LLC | 13 | $172 |
| Abbott | 1 | $160 |
| Xeris Pharmaceuticals, Inc. | 1 | $125 |
| Sanofi-aventis U.S. LLC | 7 | $101 |
| Amarin Pharma, Inc. | 4 | $54 |
| Arbor Pharmaceuticals, Inc. | 3 | $39 |
| Vifor Pharma, Inc. | 1 | $16 |
| Exact Sciences | 1 | $15 |
| Merck | 1 | $15 |
| AbbVie | 1 | $13 |
| Currax Pharmaceuticals LLC | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
| Boehringer Ingelheim | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FREESTYLE LIBRE 3$160
- AIRSUPRA$125
- GVOKE HYPOPEN$125
- Kerendia$111
How this compares
$1,426 in reported general payments places this provider in the 70th percentile of 4,032 internal medicine providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Verapamil ErVerapamil Hcl | 12 | $799 |
| Rosuvastatin Calcium | 18 | $233 |
| Valsartan | 11 | $159 |
| Atorvastatin Calcium | 14 | $148 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 16 | $101 |
| Allopurinol | 11 | $28 |
| Azithromycin | 13 | $21 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Toms River
- Samir JainToms River$32K
- Akshay PatelToms River$27K
- Ralph GuarinoToms River$26K
- David ShulkinMorristown$1.7M
- Howard UdermanLakewood$955K
- Darshi SunderamEast Orange$530K
- Annika DrongeEmerson$401K
- Stephen MarcellaNew Brunswick$331K
- Viju VijaysadanKinnelon$325K
- Mark MonaneWoodcliff Lake$268K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.